Form 4: AtriCure Director B. Kristine Johnson Acquires Shares Through Restricted Stock Award

Director B. Kristine Johnson acquired 7,788 shares of AtriCure, Inc. through a restricted stock award, which will vest in one year.

Summary

• On May 13, 2024, B. Kristine Johnson, a director of AtriCure, Inc., acquired 7,788 shares of common stock.
• The acquisition was made through a restricted stock award under the company's 2023 Stock Incentive Plan.
• These shares will vest on the one-year anniversary of the grant date.
• Following the transaction, Johnson directly owns 44,409 shares of AtriCure common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, indicating confidence in the company. However, it's a routine transaction related to compensation.

Positives

• The acquisition of shares by a director signals confidence in the company's future prospects.

Future Outlook

The restricted stock award suggests a commitment to long-term value creation, as the shares vest after one year.

Industry Context

Director share acquisitions are common in the healthcare industry and are often viewed positively by investors as they align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the director's share acquisition as a positive sign of alignment with their interests.
• Employees may see it as a sign of confidence in the company's future.

Key Dates